Jeffrey A. Golden, MD

Nina Ireland Distinguished Professor of Clinical Medicine and Surgery
University of California San Francisco
San Francisco, California

Jeffrey A. Golden, MD, is Nina Ireland Distinguished Professor of Clinical Medicine and Surgery at the University of California at San Francisco. He received his BA degree from Yale University in New Haven, Connecticut, and his medical degree from Washington University in St. Louis, Missouri. Dr. Golden completed his internship at San Francisco General Hospital. He completed his residency in internal medicine and his research fellowship at the Cardiovascular Research Institute of the University of California, San Francisco, where he studied ozone inhalation in humans as a model of asthma. Dr. Golden has been on the faculty in UCSF's Department of Medicine since 1977 and is currently Director of the Bronchoscopy Service, Medical Director of Lung Transplantation, and co–Director of the Interstitial Lung Clinic.

Dr. Golden is involved primarily with clinical practice and clinical research in three main areas of interest: bronchoscopy, interstitial lung disease, and lung transplantation. He has been responsible for specific drug trials for idiopathic pulmonary fibrosis (IPF) that include a completed initial study of gamma interferon and ongoing studies with bosentan, gamma interferon, and inhaled iloprost.

The interstitial lung disease (ILD) clinic, which Dr. Golden has developed for over 25 years, includes 6 faculty members. The UCSF ILD program was awarded a Center of Excellence Grant from the Department of Medicine on which Dr. Golden is a co–investigator. In 2005, the program was selected to be one of 11 centers in the US to receive NIH sponsorship for clinical research. Dr. Golden also initiated the UCSF lung transplant program in 1991. Since 2002 it has become one of the top 10% in the world in terms of yearly procedures

Dr. Golden has been published in numerous scientific journals, including the American Review of Respiratory Disease, Chest, the Journal of Nuclear Medicine, the Western Journal of Medicine, and the New England Journal of Medicine.

Disclosure Statement

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.

Jeffrey A. Golden, MD, has received research support from Actelion, Alnylam Pharmaceuticals, APT Pharmaceuticals, InterMune, and Johnson & Johnson.

Disclaimer
The opinions, recommendations, and guidelines expressed herein are those of the PILOT™ Steering Committee and other contributing faculty, and not necessarily those of The France Foundation or InterMune, who assume no responsibility or liability for the material that appears herein.